Latest News

Upcoming Events

DuoBody® Technology applied to generate murine bispecific antibodies

14 June 2017

The DuoBody technology is an easy-to-use method for the generation of therapeutic human IgG1 bispecific antibodies (bsAb). To facilitate the investigation of dual-targeting concepts in immuno-competent mice, we now applied and optimized our technology for the generation of murine bsAbs. This work of Labrijn et al. was recently published in Scientific Reports. Please click here to read the full article.